NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge or the Company) a global biotechnology platform company committed to accelerating access to innovative medicines, today announced the presentation of ...
Company addresses FDA requests regarding formulation excipient – Global site start-up activities continue, with first-patient-in for registrational Phase 1b study targeted for Q1 2026, subject to FDA ...
A provision in the “must-pass” National Defense Authorization Act (NDAA) bill for 2026, released by lawmakers on Monday, ...
Apple CEO Tim Cook was in Washington, D.C. today to meet with the House Energy and Commerce Committee about the upcoming App ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback